Financing Global Health 2014 is the sixth edition of this annually produced report on global health financing. As in previous years, this report captures trends in development assistance for health (DAH) and government health expenditure (GHE). Health financing is one of IHME’s core research areas..., and the aim of the series is to provide much-needed information to global health stakeholders. Updated GHE and DAH estimates allow decision-makers to pinpoint funding gaps and investment opportunities vital to improving population health. This year, IHME made a number of improvements to the data collection and methods implemented to produce Financing Global Health estimates. Both government health expenditure and development assistance for health estimates were updated and enhanced in 2013.
more
Financing Global Health 2015 is the seventh edition of IHME’s annual series on global health financing. This report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-S) in low- and middle-income countries. Annually updated GHE-S and DAH est...imates are produced to aid decision-makers and other global health stakeholders in identifying funding gaps and invesment opportunities vital to improving population health. This year, IHME made a number of improvements to the data collection and methods implemented to generate Financing Global Health estimates.
more
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...All recorded MVD
outbreaks to date have originated in Africa. MVD is not an airborne disease and is considered not to be
contagious before symptoms appear. Direct contact with the blood and other body fluids of infected people
and animals or indirect contact with contaminated surfaces and materials like clothing, bedding and medical
equipment is required for transmission. The risk of infection is minimised when proper infection prevention and
control precautions are strictly followed. There is no approved treatment or vaccine for MVD; however, several
pharmaceuticals and candidate MVD vaccines are under investigation.
more
The security situation in the Central African Republic (CAR) has remained precarious during the first seven months of 2019. The population is the main victims of the tension and violence exerted in the country despite the Political Agreement for Peace and Reconciliation signed in February 2019. Whil...e the total number of incidents affecting humanitarian organizations has been on decline for the first six months, a sharp increase was observed in July. 159 incidents directly affecting humanitarian staff or assets were witnessed during the period compared to 231 during the same period in 2018. In Bangui alone, five humanitarian vehicles were stolen at gun point in July. The Sub-prefectures of Bambari, Bria, Kaga-Bandoro, Batangafo and Bangui remain the most affected area
more
GOVERNMENT NOTICE | No. 192 Promulgation of Medicines and Related Substances Control Act, 2003 (Act No. 13 of 2003), of the Parliament
This annual report outlines achievements and challenges of delivering these partnerships. NUDOR takes this opportunity to thank all organizations, individuals and decision makers who have supported NUDOR to contribute to the promotion, respect and realization of the rights of persons with disabiliti...es.
more